BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 25575600)

  • 1. How does lipid lowering prevent coronary events? New insights from human imaging trials.
    Libby P
    Eur Heart J; 2015 Feb; 36(8):472-4. PubMed ID: 25575600
    [No Abstract]   [Full Text] [Related]  

  • 2. Atherosclerosis: Regression of coronary atherosclerosis with statin therapy.
    Huynh K
    Nat Rev Cardiol; 2014 Nov; 11(11):623. PubMed ID: 25245827
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of intensive lipid lowering on lipid profiles over time and tolerability in stable coronary artery disease: insights from a subanalysis of the coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects (COSMOS).
    Kawashiri MA; Yamagishi M; Sakamoto T; Takayama T; Hiro T; Daida H; Hirayama A; Saito S; Yamaguchi T; Matsuzaki M;
    Cardiovasc Ther; 2013 Dec; 31(6):335-43. PubMed ID: 23409830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of rosuvastatin versus atorvastatin on coronary atherosclerotic plaque volume - a systematic review and meta-analysis with trial sequential analysis of randomized control trials.
    Kumar A; Shariff M; Doshi R
    Eur J Prev Cardiol; 2020 Dec; 27(19):2138-2141. PubMed ID: 31382809
    [No Abstract]   [Full Text] [Related]  

  • 5. Integrated Biomarker and Imaging Study 3 (IBIS-3) to assess the ability of rosuvastatin to decrease necrotic core in coronary arteries.
    Oemrawsingh RM; Garcia-Garcia HM; van Geuns RJ; Lenzen MJ; Simsek C; de Boer SP; Van Mieghem NM; Regar E; de Jaegere PP; Akkerhuis KM; Ligthart JM; Zijlstra F; Serruys PW; Boersma E
    EuroIntervention; 2016 Aug; 12(6):734-9. PubMed ID: 27542785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Rosuvastatin on the Density Score of Coronary Artery Calcification in Coronary Artery Disease Patients with Type 2 Diabetes Mellitus: Rationale and Design of RosCal Study.
    Zhang W; Luan Y; Jin C; Xu S; Bi X; Zhao Y; Qiu F; Fu G; Wang M
    Clin Drug Investig; 2016 Dec; 36(12):1023-1029. PubMed ID: 27541380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Aggressive lipid-lowering treatment with Rosuvastatin on vascular endoTHelium function: evaluation of vascular endothelium function (EARTH study).
    Takayama T; Hiro T; Yoda S; Fukamachi D; Haruta H; Kogo T; Mineki T; Murata H; Oshima T; Hirayama A
    Heart Vessels; 2018 Jun; 33(6):590-594. PubMed ID: 29209775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Trends, Effectiveness, and Safety of Statins on Lipid Goal Attainment in Chinese Percutaneous Coronary Intervention Patients: a Multicenter, Retrospective Cohort Study.
    Chen Y; Li D; Jing J; Yan H; Liu J; Shen Z; James S; Varenhorst C
    Clin Ther; 2017 Sep; 39(9):1827-1839.e1. PubMed ID: 28807393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of renal function on changes of plaque characteristics in non-intervened coronary segments after rosuvastatin treatment in patients with angina pectoris and hypertension.
    Hong YJ; Jeong MH; Cho KH; Kim MC; Lee KJ; Kim KH; Kim HK; Jeong HC; Park KH; Sim DS; Kim JH; Ahn Y; Cho JG; Park JC; Kim SH; Kang JC
    Int J Cardiol; 2015; 187():286-7. PubMed ID: 25838233
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of high-dose statins on vitamin D levels and platelet function in patients with coronary artery disease.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Schaffer A; Barbieri L; Daffara V; Marino P; Bellomo G; Suryapranata H; De Luca G;
    Thromb Res; 2017 Feb; 150():90-95. PubMed ID: 28068529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [COSMOS (coronary atherosclerosis study measuring effects of rosuvastatin using intravascular ultrasound in Japanese subjects) trial].
    Nohara R
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():341-4. PubMed ID: 22724226
    [No Abstract]   [Full Text] [Related]  

  • 12. Letter by Kaneda regarding article, "Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden".
    Kaneda H
    Circulation; 2008 Nov; 118(22):e706; author reply e708-9. PubMed ID: 19029473
    [No Abstract]   [Full Text] [Related]  

  • 13. Letter by Sutton et al regarding article, "Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden".
    Sutton BS; Blumenthal RS; Kapur NK
    Circulation; 2008 Nov; 118(22):e707; author reply e708-9. PubMed ID: 19029474
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pronounced lowering of low density cholesterol combined with elevation of high density cholesterol was associated with reduction of coronary atheroma. Results of ASTEROID trial].
    Gratsianskiĭ NA
    Kardiologiia; 2006; 46(5):71-3. PubMed ID: 16858362
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of intensive lipid-lowering therapy on coronary plaques composition in patients with acute myocardial infarction: Assessment with serial coronary CT angiography.
    Auscher S; Heinsen L; Nieman K; Vinther KH; Løgstrup B; Møller JE; Broersen A; Kitslaar P; Lambrechtsen J; Egstrup K
    Atherosclerosis; 2015 Aug; 241(2):579-87. PubMed ID: 26115069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
    Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
    Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of statins on sirtuin 1 and endothelial nitric oxide synthase expression: the role of sirtuin 1 gene variants in human coronary atherosclerosis.
    Kilic U; Gok O; Elibol-Can B; Uysal O; Bacaksiz A
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):321-30. PubMed ID: 25582759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of high-intensity statin therapy on atherosclerosis in non-infarct-related coronary arteries (IBIS-4): a serial intravascular ultrasonography study.
    Räber L; Taniwaki M; Zaugg S; Kelbæk H; Roffi M; Holmvang L; Noble S; Pedrazzini G; Moschovitis A; Lüscher TF; Matter CM; Serruys PW; Jüni P; Garcia-Garcia HM; Windecker S;
    Eur Heart J; 2015 Feb; 36(8):490-500. PubMed ID: 25182248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of rosuvastatin therapy and percutaneous coronary intervention on angiogenic growth factors in coronary artery disease patients.
    Semenova AE; Sergienko IV; Masenko VP; Ezhov MV; Gabrusenko SA; Kuharchuk VV; Belenkov YN
    Acta Cardiol; 2009 Jun; 64(3):405-9. PubMed ID: 19593954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin and Mean Platelet Volume in Diabetes.
    Papanas N; Maltezos E
    Angiology; 2016 Feb; 67(2):113-5. PubMed ID: 26085194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.